Contact Us

Progressive Multifocal Leukoencephalopathy
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

   * Phone 

Cell Phone 

If you believe PML is due to an Multiple Sclerosis drug, please list drug:

Please describe your case:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Parker Waichman LLP Headlines by Topic

PML

Rituxan - PML Link Could Spark FDA Action

Jun 1, 2009
| Parker Waichman LLP
U.S. health regulators are taking a look at the lymphoma drug Rituxan because of its possible association with progressive multifocal...

Raptiva Gets Black Box Warning for PML, Other Opportunistic Infections

Oct 17, 2008
| Parker Waichman LLP
The labeling  of the psoriasis drug Raptiva will now bear a new black box warning about its association with the deadly brain disease...

Raptiva Added to List of Drugs Linked to Deadly Brain Disease

Oct 6, 2008
| Parker Waichman LLPp
Raptiva, Genentech Inc’s psoriasis drug, may be linked to a deadly brain disease called progressive multifocal leukoencephalopathy, or...

Biotech firms' drug is linked to deaths

Dec 19, 2006
| Los Angeles Times
The bestselling medicine for two of the country's biggest biotech drug companies has been further linked to a rare and deadly brain infection, U.S....

Biogen, Genentech issue warning for Rituxan

Dec 19, 2006
| www.cbsmarketwatch.com
Biogen Idec and Genentech have issued a warning to healthcare providers for their oncology drug Rituxan, advising them that the drug has been linked...

Rituxan (rituxamab) Linked to Two Deaths in Lupus Patients

Dec 19, 2006
| www.medpagetodaycom
Two patients treated with the immune modulator Rituxan (rituximab) for systemic lupus erythmatosus (SLE) have died of progressive multifocal...

Off-Label Use of Rituxan Linked to Fatal Leukoencephalopathy

Dec 19, 2006
| www.medscape.com
The US Food and Drug Administration (FDA) is warning healthcare professionals regarding the risk for progressive multifocal leukoencephalopathy (PML)...

Rituxan warning issued by FDA

Dec 19, 2006
| North County Times
Patients treated with Rituxan may be at risk from a rare, fatal brain infection, the U.S. Food and Drug Administration warned Monday. The FDA said...

FDA ALERT

Dec 18, 2006
| www.fda.gov
This Alert highlights important emerging safety information about Rituxan. Two patients have died after being treated with Rituxan for systemic lupus...

Life-threatening Brain Infection in Patients with Systemic Lupus Erythematosus

Dec 18, 2006
| www.fda.gov
FDA has received reports of the death of two patients who were treated with Rituxan for systemic lupus erythematosus (SLE).  Both patients...

Page 1/2 [first] [prev] 1 2 [next] [last]